Evaluation of Glistenings in Intraocular Lenses Implanted in Normal Patients Following Routine Cataract Extraction. (AVS Vs MA50BM)

Fry Eye Associates and Fry Eye Surgery Center

Status and phase: Withdrawn; Phase 4

Conditions: Glistenings

Treatments: Device: Intraocular lens

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01131481

Protocol Number 7248

Details and patient eligibility

About

Evaluation of glistenings in intraocular lenses implanted in normal patients following routine cataract surgery. The lenses used will be Model X-60 made by the AVS company Vs AcrySof MA50BM made by the Alcon company.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years or older
• Bilateral cataracts requiring surgery
• Potential visual acuity of 20/40 or better in both eyes
• Require IOL power in range of 15-25 diopters
• Pupillary dilation of at least 6mm
• Willing and able to provide informed consent and attend follow-up appointments to 3 years

Exclusion criteria

• Any co-existing ocular disease or previous ocular surgery that would confound findings in the study, especially those effecting quality of vision. Examples include Macular degeneration amblyopia and prior epiretinal membrane peel.

Trial design

0 participants in 1 patient group

AcrySof MA50BM,AVS Model X-60

Other group

Description:

AcrySof MA50BM, AVS Model X-60

Treatment:

Device: Intraocular lens